PharmaVOICE - 
May 2006
Purchase Issue

In Every Issue
What’s on Your Mind — Opinions
Alternatives to the integrated pharmaceutical company business model are taking [...]
By
Letter from the Editor
In this day and age when individuals are granted almost [...]
By

Taren Grom, Editor

E-Media
New Electronic and Web-based Applications, Sites, and Technologies McGraw-Hill’s Access [...]
By
PharmaOutlet
Short-Dated Drugs: Pharma’s Options Contributed by John Matthews The World [...]
By

John Matthews

Talent Pool
Pharma POOL Seung Baick James Bruno Advancis Strengthens Sales and [...]
By
UpFront
Biotech pioneer recognized Dr. Zaffaroni Receives 2006 Biotech Heritage Award [...]
By
On the Calendar
May 10 2006 HBA Woman of the Year Luncheon Hilton [...]
By
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Opportunities and [...]
By
What’s New
Ventiv Health Changes Name to Reflect Broader Capabilities Rebranding initiative [...]
By

On The Cover

Creative Marketing: New Challenges, New Attitudes, New Tools
To meet the challenges presented by a number of converging factors that are impacting the status quo, marketers are turning to a vast array of tools. Experts view specialized direct-to-patient communications as the wave of pharma marketing’s future. Programs that include focused messages to targeted groups are expected to receive increased funding in 2006 and [...]
By

Elisabeth Pena Villarroel

Features

Avoiding Undue Influence
Thought leaders — scientific and clinical experts — play a pivotal role in helping pharma companies identify key topics of interest to physicians. Depending on their role, these KOLs provide launch and sales support or play a critical role in continuing medical education. They provide solid, evidenced-based education that translates science into practical application and [...]
By

Autumn Konopka

Star Quality
PharmaVOICE is once again honored to pay tribute in the following pages to the Healthcare Businesswomen’s Association (HBA) Rising Stars. The Class of 2006 represents a wide range of disciplines, company types, and levels of accomplishment. These women have one thing in common: they have been identified as valued and true assets to their organizations. [...]
By

Taren Grom, Editor

A Model for Success
Alternatives to the integrated pharmaceutical company business model — such as development-only or hybrid models — are taking hold as smaller players contribute to the industry’s value chain. Ansbert Gadicke MPM Capital The development-only business model makes complete sense, but it is extremely difficult to execute. The usual suspects — rising R&D costs, the introduction [...]
By

Denise Myshko

The Role of District Sales Managers in Maximizing Incentive Program Spend
Spend Stan Striker, VP, Managing Consultant, of Maritz Incentives discusses why salesforce member retention is a pressing concern for companies; the cost of turnover may be as much as one and a half times an employee’s first year salary. Being on the front line of working with the salesforce, district managers have unique insights on [...]
By
Combination Products: Drugs and Devices
The possibilities are endless. Emerging drug-delivery technologies and smarter drug-development strategies are providing a one-two punch for researchers and marketers who envision scientific advancements that could span multiple therapeutic categories. By Denise Myshko In the broadest sense, pharmaceuticals and their delivery systems, such as asthma inhalers, are considered combination products, but Cordis Corp.’s Cypher stent [...]
By

Denise Myshko

A Journey of a Lifetime — Leslie Williams
Leslie Williams, the president and CEO of Ventaira Pharmaceuticals, is driven by a desire to advance the frontiers of medicine. She melds that goal with a passion for life, a dedication to family, and pure, unadulterated hard work. May 2006 PharmaVOICE A Journey of a Lifetime — Leslie Williams Leslie Williams is driven by a [...]
By

Kim Ribbink

FEEDBACK